Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine versus olanzapine for borderline personality disorder
ACTRN12614000551695Phase 4Recruiting
- Sponsor
- Centre for Personality Disorders
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in borderline personality disorder (BPD) comparing Asenapine with Olanzapine (2 arms). Primary endpoint: Global symptoms. Started May 2014; status: recruiting.
02
Drugs
asenapineolanzapine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on ACTRN12614000551695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000551695.